Adolescent Depression

New Study:
Repetitive Transcranial Magnetic Stimulation as a Treatment for Depression in Adolescents

agertms

What is the study about?
This study is examining Repetitive Transcranial Magnetic Stimulation (rTMS) as a treatment for adolescents with depression.

What is rTMS?
rTMS is a treatment that uses magnetic pulses to change the activity of nerve cells in the part of the brain that is thought to be related to depression. rTMS has been shown to be an effective treatment for depression and anxiety in many individuals, however it is important to note that this treatment is not effective for everyone.

Who can take part?

Adolescents aged 13 to 18 that have a current diagnosis of major depressive disorder (MDD) may be eligible to take part in this study. Adolescents may still be able to take part if they also have a secondary diagnosis of dysthymic disorder, Attention Deficit Hyperactivity Disorder, a personality disorder, or an anxiety disorder. All adolescents that take part will be required to be actively managed by a clinician outside of the study (e.g. by a private psychiatrist, or by a public mental health service) for the duration of their participation.

Adolescents are not able to take part if

  • they live outside of Victoria.
  • they have received electroconvulsive therapy (ECT) for their current episode of depression.
  • they have a current diagnosis of a major DSM-IV Axis I disorder (e.g. schizophrenia, Bipolar Affective Disorder, Intellectual Disability, a restrictive eating disorder, or a developmental disorder such as autism).
  • they have metal in their cranium, a pacemaker, a cochlear implant, a medication pump, or any other implanted electronic device.
  • they have a current history of alcohol or drug dependence.
  • they have a history of neurologic illness (including epilepsy), past neurosurgical procedure, or a severe medical illness (such as cardiovascular disease).
  • they are pregnant.
  • written informed consent will be obtained from all adolescents before they take part in the study, and from a parent or guardian (if appropriate).

 

Is it safe?
rTMS is a safe treatment for most people, however there are some risks. Some people that receive rTMS experience temporary mild discomfort such as headache or neck ache. There is also a very small risk that rTMS can induce a seizure. This is very rare, and there are safety procedures in place to minimise the chance of this occurring.

How do I sign up?
Adolescents that would like to take part in this study will need to be referred by their treating clinician, such as a private psychiatrist, a private psychologist, or a clinician at a public mental health service. A member of the research team will need to speak with the clinician to determine if rTMS is suitable. It is important to note that all adolescents that take part in this study will need to continue to be actively managed by a clinician outside of the study for the duration of their participation.

Who do I contact for more information?
If you are interested in finding out more information about participating in the study please get in touch via the contact details or online form below: 

Phone: 0420 371 052
Email: emily.wallman@monashhealth.org

For enquires regarding donations please contact the Monash Health Foundation: 

Phone: 03 9594 2700
Email: foundation@monashhealth.org

This study is proudly supported by Woolworths

woolworths